Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

URIDINE TRIACETATE for Chemotherapy toxicity attenuation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 56 adverse event reports in the FDA FAERS database where URIDINE TRIACETATE was used for Chemotherapy toxicity attenuation.

Most Reported Side Effects for URIDINE TRIACETATE

Side Effect Reports % Deaths Hosp.
Complication associated with device 20 18.2% 2 1
Diarrhoea 19 17.3% 4 4
Vomiting 19 17.3% 4 5
Off label use 14 12.7% 1 2
Thrombocytopenia 10 9.1% 4 5
Nausea 9 8.2% 4 3
Neutropenia 9 8.2% 6 5
Hypokalaemia 8 7.3% 0 0
Inappropriate schedule of product administration 8 7.3% 3 0
Mucosal inflammation 7 6.4% 3 3
Death 6 5.5% 6 0
Stomatitis 5 4.6% 0 4

Other Indications for URIDINE TRIACETATE

Toxicity to various agents (11)

Other Drugs Used for Chemotherapy toxicity attenuation

LEUCOVORIN (38) LEVOLEUCOVORIN (32) METHYLPREDNISOLONE (27) ONDANSETRON (16) FILGRASTIM (7) FOLIC ACID (7) CYANOCOBALAMIN (6) APREPITANT (5)

Related Pages

URIDINE TRIACETATE Full Profile All Chemotherapy toxicity attenuation Drugs URIDINE TRIACETATE Demographics URIDINE TRIACETATE Timeline